Misdemeanor Charges Drive FDA's Park Doctrine Enforcement
This article was originally published in The Tan Sheet
Executive Summary
FDA will push harder for federal prosecutors to take misdemeanor cases as the agency ramps up use of the Park Doctrine and strict liability statutes to prosecute corporate executives and others
You may also be interested in...
FDA Posts Criteria For Targeting Executives As Responsible Officers
FDA publishes criteria for filing criminal misdemeanor charges against executives from firms that break food and drug laws almost a year after the agency signaled its intent to pursue such cases.
RAPS Annual Conference In Brief
FDA's supplement GMP focus evolves
FDA Targets Executives With Powerful Misdemeanor Strategy
Executives could face virtually unbeatable government criminal prosecutions and prison sentences more frequently if FDA follows recently announced enforcement plans, industry attorneys warn